Bioburden Testing in Enhancing Pharmaceutical and Medical Device...

added article Health

2024-07-23 08:34:27 -

Bioburden Testing in Enhancing Pharmaceutical and Medical Device Safety

The Bioburden Testing Market Size is projected to rise from USD 1.40 Billion in 2024 to USD 3.30 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.30% during the forecast period. The Bioburden Testing Market has witnessed significant growth in recent years, fueled by the increasing emphasis on maintaining product quality and patient safety in the medical device...

0 Comments 0 Shares 531 Views 0 Reviews